Publication Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide. Shannon E, Noveck R, Sandoval FG, et al. Immunopharmacology and immunotoxicology. 2008; 30 (3) : 447-57.
Publication Thalidomide and thalidomide transformed by pH-dependent hydrolysis or by liver enzyme treatment does Not impede the proliferation of endothelial cells. Shannon E J, Sandoval F G. Immunopharmacology and immunotoxicology. 2008; 30 (2) : 307-16.
Publication Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction. Tadesse A, Abebe M, Bizuneh E, et al. Immunopharmacology and immunotoxicology. 2006; 28 (3) : 431-41.
Publication Enhancement of human T cell response to a peptide epitope of 38 kDa antigen of Mycobacterium tuberculosis by liposomes. Bala L, Anand S, Sinha S. Immunopharmacology and immunotoxicology. 2002; 24 (2) : 255-63.
Publication Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, selectively augments human T cell response to mycobacterial protein antigens. Sinha S, Mehrotra J, Bala L, et al. Immunopharmacology and immunotoxicology. 1998; 20 (4) : 579-88.
Publication Thalidomide does not perturb CD2, CD4, CD5, CD8, HLA-DR, or HLA-A, B, C molecules in vitro on the membranes of cells with immune potential. Shannon E J, Howe R C, McLean K, et al. Immunopharmacology and immunotoxicology. 1994; 16 (4) : 717-29.